OGLCX | RNPHX | OGLCX / RNPHX | |
Total Expense Ratio | 1.82 | 0.56 | 325% |
Annual Report Gross Expense Ratio | 1.82 | 0.56 | 325% |
Fund Existence | 30 years | 10 years | - |
Gain YTD | 6.720 | 12.630 | 53% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 9.18B | 155B | 6% |
Annual Yield % from dividends | 0.00 | 0.67 | - |
Returns for 1 year | -5.22 | 9.04 | -58% |
Returns for 3 years | 6.36 | 45.83 | 14% |
Returns for 5 years | -9.66 | 40.69 | -24% |
Returns for 10 years | -0.11 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 21.88 | 0.28 | +1.30% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
IWL | 155.62 | 0.84 | +0.54% |
iShares Russell Top 200 ETF | |||
FFGX | 28.76 | 0.15 | +0.54% |
Fidelity Fundamental Global ex-U.S. ETF | |||
GJUN | 37.81 | 0.12 | +0.32% |
FT Vest U.S. Eq Mod Buffr ETF - Jun | |||
YSEP | 24.28 | 0.04 | +0.17% |
FT Vest Intl Eq Mod Bfr ETF Sep |